-
-
-
-
-
-
-
UBS Reiterates Buy Rating on Eli Lilly (LLY) on Deal to Acquire ATAI
-
-
-
-
-
-
-
Pfizer targets obesity market with monthly weight-loss injection data
-
-
-
-
-
-
-
Lilly to showcase oncology portfolio across tumor types and treatment modalities at the 2026 American Society of Clinical Oncology Annual Meeting
-
-
-
-
-
-
-
RBC Capital on Eli Lilly (LLY): Kelonia acquisition payment 'may appear full,' but strategically justified
-
-
-
-
-
-
-
BMO Capital on Eli Lilly (LLY): Centessa deal positive for shares; 'diversifying business ahead of any major LOEs'
-
-
-
-
-
-
-
Lilly to acquire Orna Therapeutics to advance cell therapies
-
-
-
-
-
-
-
Ventyx Biosciences (VTYX) halted on volatility following WSJ report
-
1,186,409 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

